-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Chemical Machinery Equipment Network Market Analysis ] In April, the first quarter performance forecasts of listed companies have been disclosed one after another.
Among them, companies in the field of pharmaceutical equipment have also begun to publish transcripts.
On April 2, Tofflon issued a performance forecast showing that the net profit attributable to the parent in the first quarter of 2021 is expected to be 108 million to 123 million yuan, a year-on-year increase of 130%-160%.
As the company's sales continue to be good, operating performance has steadily increased; it is estimated that the impact of non-recurring gains and losses on net profit is about 10 million yuan.
Chemical machinery and equipment network market analysis chemical machinery and equipmentAmong them, companies in the field of pharmaceutical equipment have also begun to publish transcripts.
On April 2, Tofflon issued a performance forecast showing that the net profit attributable to the parent in the first quarter of 2021 is expected to be 108 million to 123 million yuan, a year-on-year increase of 130%-160%.
As the company's sales continue to be good, operating performance has steadily increased; it is estimated that the impact of non-recurring gains and losses on net profit is about 10 million yuan.
Regarding the sharp increase in performance in the first quarter, it stated in the report that it was mainly due to the company's continuous improvement of its business management capabilities and order delivery capabilities around the "systematic, optimized, and digital" development strategy and market demand.
Sales continued to be good and operating performance Steady rise leads.
Sales continued to be good and operating performance Steady rise leads.
It is worth mentioning that although not all pharmaceutical equipment companies have seen their performance growth, the industry believes that the performance of many pharmaceutical equipment companies in the first quarter is relatively optimistic.
In fact, in addition to Teflon recently, Xinlai Yingcai also replied to investors on the interactive platform on March 14 that the company has sufficient orders and production is very busy.
In this regard, the industry believes that the current pharmaceutical equipment industry as a whole is showing a scene of busy production and delivery.
In fact, in addition to Teflon recently, Xinlai Yingcai also replied to investors on the interactive platform on March 14 that the company has sufficient orders and production is very busy.
In this regard, the industry believes that the current pharmaceutical equipment industry as a whole is showing a scene of busy production and delivery.
The cause of this status quo, after analysis by the industry, said that there are several main factors.
Among them, from a market perspective, due to the expansion of production capacity of some drugs in the first quarter, in order to meet market supply, the demand for related pharmaceutical equipment will also continue to expand.
From a corporate perspective, good cost control of pharmaceutical equipment companies and active communication with downstream customers to ensure the successful completion of current delivery are important factors for some companies to achieve performance growth in the first quarter.
In addition, the continued spread of foreign epidemics has led to the expansion of overseas business of pharmaceutical equipment companies, which may also contribute to the growth of corporate performance.
Pharmaceutical equipmentAmong them, from a market perspective, due to the expansion of production capacity of some drugs in the first quarter, in order to meet market supply, the demand for related pharmaceutical equipment will also continue to expand.
From a corporate perspective, good cost control of pharmaceutical equipment companies and active communication with downstream customers to ensure the successful completion of current delivery are important factors for some companies to achieve performance growth in the first quarter.
In addition, the continued spread of foreign epidemics has led to the expansion of overseas business of pharmaceutical equipment companies, which may also contribute to the growth of corporate performance.
Of course, as the performance of related companies continues to improve, the industry naturally shows a trend of prosperity.
According to data, the year-on-year growth rates of fixed asset investment in the pharmaceutical manufacturing industry for the whole year of 2020 and January-February 2021 are 28.
4% and 64% respectively.
From an overall point of view, the decline in revenue and net profit in my country's pharmaceutical equipment industry since the end of the GMP certification peak has been improved, and the overall rebound trend is obvious.
According to data, the year-on-year growth rates of fixed asset investment in the pharmaceutical manufacturing industry for the whole year of 2020 and January-February 2021 are 28.
4% and 64% respectively.
From an overall point of view, the decline in revenue and net profit in my country's pharmaceutical equipment industry since the end of the GMP certification peak has been improved, and the overall rebound trend is obvious.
In fact, medicine is just needed.
Under the background of the continued development of the pharmaceutical industry, the pharmaceutical equipment industry, as the upstream of the pharmaceutical industry, will naturally also face greater opportunities.
It is understood that the current pharmaceutical equipment actually belongs to the high-quality subdivision track in the machinery industry, and the industry is already in a rapid development stage in the context of the expansion of the manufacturing PMI and the sharp increase in profits in the machinery industry.
It is reported that my country's pharmaceutical equipment industry has formed a complete, independent and complete industrial system.
The number of enterprises, small scale, scattered distribution, low level, and market chaos are gradually improving, and the industry concentration is also increasing.
Under the background of the continued development of the pharmaceutical industry, the pharmaceutical equipment industry, as the upstream of the pharmaceutical industry, will naturally also face greater opportunities.
It is understood that the current pharmaceutical equipment actually belongs to the high-quality subdivision track in the machinery industry, and the industry is already in a rapid development stage in the context of the expansion of the manufacturing PMI and the sharp increase in profits in the machinery industry.
It is reported that my country's pharmaceutical equipment industry has formed a complete, independent and complete industrial system.
The number of enterprises, small scale, scattered distribution, low level, and market chaos are gradually improving, and the industry concentration is also increasing.
In addition, in recent years, pharmaceutical equipment companies are still using sweat to harvest.
Through continuous innovation, a large number of new * equipment, technologies, processes, and new solutions have begun to emerge one after another: such as new preparation process equipment, large-scale biological reactors and ancillary systems, efficient protein separation and purification equipment, flexible sterile formulation production line, continuous production of solid dosage equipment.
reactorThrough continuous innovation, a large number of new * equipment, technologies, processes, and new solutions have begun to emerge one after another: such as new preparation process equipment, large-scale biological reactors and ancillary systems, efficient protein separation and purification equipment, flexible sterile formulation production line, continuous production of solid dosage equipment.
It is worth noting that due to the influence of economicization, the intensification of industrialization competition, and the upgrading of the domestic equipment market, the low-end price war of pharmaceutical equipment companies in the past has actually been changed.
*Equipment is increasingly becoming an important choice for pharmaceutical companies.
.
In the context that medical equipment has gradually become one of the main strategies of many pharmaceutical equipment companies, and the competition between companies will gradually focus on the origin of product value, the industry suggests that my country’s pharmaceutical equipment companies should find ways to seize the *market and promote* The pharmaceutical equipment market continues to grow.
*Equipment is increasingly becoming an important choice for pharmaceutical companies.
.
In the context that medical equipment has gradually become one of the main strategies of many pharmaceutical equipment companies, and the competition between companies will gradually focus on the origin of product value, the industry suggests that my country’s pharmaceutical equipment companies should find ways to seize the *market and promote* The pharmaceutical equipment market continues to grow.
In general, the entire domestic pharmaceutical equipment industry has entered a new round of business cycle.
The industry predicts that in the next three quarters of 2021, my country's pharmaceutical equipment industry will achieve another success, and the performance of related companies may also be further improved.
The industry predicts that in the next three quarters of 2021, my country's pharmaceutical equipment industry will achieve another success, and the performance of related companies may also be further improved.
Original title: The development of the pharmaceutical equipment industry continues to improve, a large number of companies may be happy in the first quarter
